The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...

Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE™ Platform for the treatment of drug ...

Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has done it again.

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing ...

AtriCure stock rose more than 16% on news of plans to expand into pulsed field ablation, a tech that could potentially better treat AFib.

Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation ...

The Affera mapping and ablation system is the first on the market that can deliver both pulsed-field and radiofrequency ...

This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.

Woodland Heights Medical Center is pleased to announce treatment of its first patient with a new system that used Pulsed ...

Affera combines mapping technology with a catheter capable of performing radiofrequency and pulsed field ablation.